In a phase 1, randomized, placebo-controlled, dose-escalation trial, PEGylated uricase (PEG-UOX) safely and effectively lowered serum uric acid levels over 21 days in adults with and without hyperuricemia. Results of the study, conducted by…
- Cardiovascular (CV) disease is the primary cause of…